The Cyprus IP Box: 3% tax on income from software and patents
An 80% deduction on qualifying IP profit puts the effective rate near 3%. Which assets qualify, why trademarks do not, and how the nexus rule limits it.
If your company earns money from software you wrote or a patent you hold, the IP Box is the largest tax break available to you in Cyprus — and it is one of the few that survived the 2026 reform untouched.
What it actually does
80% of qualifying profit from a qualifying intangible asset is deducted before tax. Only the remaining 20% is taxed, at the normal corporate rate.
Corporate tax rose from 12.5% to 15% on 1 January 2026. So the arithmetic is now:
| Qualifying profit | €100,000 |
| 80% notional deduction | −€80,000 |
| Taxable | €20,000 |
| Tax at 15% | €3,000 |
An effective rate of about 3%. You will still see "2.5%" quoted all over the internet — that was correct while corporate tax was 12.5%, and it has not been updated on most sites. The relief is unchanged; the rate underneath it moved.
Which assets qualify
- Patents — Cyprus, European Patent Office, or a PCT national-phase patent
- Copyrighted software
- Utility models and plant variety rights
- Other intangibles that are non-obvious, useful and novel, certified as such by a competent authority, where the company meets the size conditions
Which do not — and this is where people are disappointed
Marketing intangibles are excluded. Trademarks, brand names, image rights, customer lists, franchise agreements and goodwill do not qualify, however valuable they are.
This catches out founders who assume "our brand is our IP". For IP Box purposes it is not. What qualifies is the thing you built and can point to as an invention or as code.
What counts as qualifying income
- Royalties and licence fees for the use of the asset
- Embedded income — the IP-derived part of the price of a product you sell, even when nobody pays you a separate royalty. This is the route most software companies actually use
- Capital gains on disposal of the asset
- Compensation or insurance proceeds relating to it
The nexus rule: the part that decides how much you get
The regime follows the OECD modified nexus approach. In plain terms: the benefit is proportional to how much of the R&D your own company actually did and paid for.
Spending on your own development counts. Buying the IP in, or paying a related company abroad to develop it, does not count towards your ratio — so a company that acquires finished IP and licenses it out gets little or nothing here, while a company whose developers are on its own payroll gets close to the full benefit.
This is deliberate. The rule exists so the relief goes to businesses genuinely doing the work in Cyprus, and it means the IP Box is not a structure you can bolt on at year end. It rewards how the company is actually built.
The nexus fraction, with numbers
(qualifying expenditure + uplift of up to 30%) ÷ overall expenditure, capped at 1
Qualifying expenditure is what the company spent developing the asset itself: developer salaries, contractors, and work outsourced to unrelated third parties, wherever they are.
Overall expenditure is that, plus the cost of acquiring the IP, plus development paid to related companies.
The 30% uplift is added to the numerator, capped at the total of acquisition and related-party costs, and it cannot push the fraction above 1. It exists so that a company doing genuine development is not punished for some of the work sitting inside the group.
Worked example
A company builds a product: €400,000 on its own salaries and outside contractors, €100,000 paid to a related company abroad. The product earns €600,000 in the year, with €300,000 profit.
| Qualifying expenditure | €400,000 |
| 30% uplift, capped at €100,000 | +€100,000 |
| Overall expenditure | €500,000 |
| Nexus fraction | 500,000 / 500,000 = 1.0 |
| Qualifying profit | €300,000 |
| 80% deduction | −€240,000 |
| Taxable | €60,000 |
| Tax at 15% | €9,000 |
Against €45,000 without the regime — €36,000 saved in the year.
Had the company bought finished IP for €400,000 instead of building it, qualifying expenditure would be nil, the uplift would be 30% of nothing, the fraction would be zero and there would be no relief at all. That is the nexus rule doing exactly what it was designed to do.
Who it is for
- Software companies and development studios, especially with embedded income in a product price
- Businesses holding patents on something they invented
- Founders relocating a development team to Cyprus, where the R&D spend will sit in the Cypriot company
It combines well with non-domicile status: the company pays about 3% on qualifying profit, and a non-dom owner takes the remainder out as dividends with no Special Defence Contribution.
The other relief you should be claiming
Most articles about the IP Box stop at the IP Box. There is a second incentive that applies to the same companies and stacks with it.
The R&D super-deduction gives you 120% of qualifying research and development expenditure — spend €100 on eligible R&D and €120 comes off taxable income. It was extended as part of the 2026 reform and applies to qualifying expenditure incurred up to 31 December 2030.
Broadly qualifying:
- Salaries and employer contributions for staff directly engaged in R&D
- Materials and consumables used in the work
- Software used directly in the R&D
- Unrelated third-party contracted R&D
- A reasonable allocation of R&D overheads
Broadly not qualifying: routine product development and incremental improvements, market research, capital spending on buildings and equipment, and R&D paid to related parties.
Notice that the exclusions echo the nexus rule almost exactly: own work and unrelated contractors count, related-party work does not. The two reliefs pull in the same direction, which is the point. A company that builds its own product with its own team gets an enhanced deduction on the way in and an 80% deduction on the profit that comes out.
It needs contemporaneous records — project objectives, cost allocations, timesheets, contractor agreements — assembled as you go, not reconstructed afterwards. Which is the same discipline the IP Box needs, so it is one piece of work, not two.
Income embedded in the price of a product
This is where the regime is most often underestimated. IP Box is not only about royalties.
The Ministry of Finance's own wording covers royalty income, embedded income and other qualifying income. Embedded income is intellectual-property income built into the price of something you sell: software shipped with a device, a patented component inside a product, an algorithm the customer pays for as part of a subscription.
A company that licenses nothing to anyone and receives not a single royalty can still have qualifying income. Separating that share from total revenue is an accounting job, and it has to be set up at the start rather than a year later.
When to set it up: before the income, not after
The regime does not apply retrospectively to what has already happened. The nexus fraction rests on development expenditure actually incurred, and if the development sat in another company or was paid for by a related party, the fraction is already fixed — it cannot be repaired afterwards.
Hence the practical rule: decide the structure before the asset starts earning, and ideally before development starts. Companies that arrive with a finished product asking to "put it in the IP Box" often find the benefit is close to nothing, because somebody else paid for the work.
What the Tax Department will ask for
An examination runs on the documents behind the return, not the return itself:
- What establishes the right to the asset, and its qualification
- Income split by asset — which income came from which
- Development costs tied to the asset and the period
- What your own employees did, and what unrelated contractors did
- The nexus fraction calculated for each year, not once at set-up
Records kept as the work happened survive examination. Records reconstructed after a request usually do not.
One more deduction for the same companies
Expenditure by a company or an individual on acquiring shares in innovative enterprises is deductible from taxable income — a measure running until 31 December 2026 under the EU General Block Exemption Regulation.
It is separate from the IP Box, but aimed at the same audience: if you are investing in a Cyprus start-up, that deadline is closer than it looks.
What it requires of you
Real accounting. You need to be able to show which income came from which asset, and which costs were incurred developing it. That means the books have to separate qualifying from non-qualifying income from the start — reconstructing it afterwards is painful and sometimes impossible.
The deduction is calculated annually, on each asset, and it needs supporting records that stand up to review.
Common mistakes
Assuming the brand qualifies. Trademarks are excluded.
Buying IP and expecting the full benefit. The nexus ratio reduces it, often to very little.
Still planning around 2.5%. The rate is about 3% from 2026.
Leaving the bookkeeping until the year end. Qualifying income has to be traceable, not estimated.
Treating it as the only decision. The IP Box sits inside a wider picture — substance, salaries, dividends and the owner's personal tax position all interact.
What we do
We assess whether your asset and your structure actually qualify before anything is committed — including the uncomfortable answer, that some businesses do not qualify and should not restructure hoping to.
Where it does fit, we set it up: the company, the ownership of the asset, the accounting separation that makes the annual calculation possible, and the coordination with your accountant so the deduction is claimed correctly each year rather than argued about later.
Legal and tax advice comes through our partners. We work with lawyers and tax advisers, so you are not left to find them yourself: the calculation and the signature sit with the tax adviser and auditor, the IP rights with a lawyer, and the coordination, documents and deadlines with us. One point of contact for the whole thing.
This is a paid service. The figures above are the framework, not advice on your specific case. Tell us what your company does and where the development happens, and we will tell you honestly whether this is worth pursuing.
If the software you are claiming for produces data worth reading, dashboards and models are a separate question we can also answer.
Common questions
Yes. The R&D super-deduction gives 120% of qualifying research and development expenditure, so 100 euro spent deducts 120 euro from taxable income. It applies to expenditure incurred up to 31 December 2030 and stacks with the IP Box.
A tax regime under which 80% of qualifying profit from intellectual property is deducted before tax. Only the remaining 20% is taxed at the corporate rate, giving an effective rate of about 3%.
About 3%. Corporate tax rose to 15% on 1 January 2026 and the 80% deduction leaves 20% taxable. The 2.5% figure quoted widely online was correct when corporate tax was 12.5%.
Patents, copyrighted software, and other intangibles that are non-obvious, useful and novel where certified. Trademarks, brand names, image rights and customer lists do not qualify.
Qualifying expenditure plus an uplift of up to 30%, divided by overall expenditure, capped at 1. Qualifying profit is overall income multiplied by that fraction.
The company's own development costs — salaries and contractors — and research and development outsourced to unrelated third parties. Buying the IP in, or paying a related company to develop it, does not count.
Usually not, or barely. The nexus fraction ties the benefit to development the company did and paid for itself, so acquired IP produces little or no relief.
Assessing eligibility takes days. Setting up the accounting separation and documentation that make the annual calculation possible takes weeks. The deduction itself is claimed in the annual tax return.